Get the Stockscreener App
2.39
2.58%
0.06
Climb Bio Inc stock is traded at $2.39, with a volume of 646.28K.
It is up +2.58% in the last 24 hours and up +37.36% over the past month.
Climb Bio Inc is a clinical-stage biotechnology company developing therapeutics for patients with immune-mediated diseases. its product candidate, budoprutug, is an anti-CD19 monoclonal antibody that has demonstrated B-cell depletion and has the potential to treat a broad range of B-cell-mediated diseases.
See More
Previous Close:
$2.33
Open:
$2.38
24h Volume:
646.28K
Relative Volume:
1.32
Market Cap:
$161.96M
Revenue:
-
Net Income/Loss:
$-64.20M
P/E Ratio:
-1.1116
EPS:
-2.15
Net Cash Flow:
$57,000
1W Performance:
+7.17%
1M Performance:
+37.36%
6M Performance:
+69.50%
1Y Performance:
+0.00%
1-Day Range:
$2.35
$2.43
1-Week Range:
$2.12
$2.49
52-Week Range:
$1.05
$5.47
Climb Bio Inc Stock (CLYM) Company Profile
Name
Climb Bio Inc
Sector
Industry
Phone
1-866-857-2596
Address
20 WILLIAM STREET, WELLESLEY HILLS
Compare CLYM with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
CLYM
Climb Bio Inc
|
2.39 | 157.89M | 0 | -64.20M | 57,000 | -2.15 |
|
VRTX
Vertex Pharmaceuticals Inc
|
396.12 | 101.77B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
573.38 | 60.12B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
452.00 | 59.45B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
750.78 | 44.90B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
341.80 | 35.07B | 3.81B | -644.79M | -669.77M | -6.24 |
Climb Bio Inc Stock (CLYM) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Aug-15-25 | Initiated | Robert W. Baird | Outperform |
| Jun-06-25 | Initiated | Oppenheimer | Outperform |
| May-22-25 | Initiated | BTIG Research | Buy |
| Dec-02-24 | Initiated | Leerink Partners | Outperform |
Climb Bio Inc Stock (CLYM) Latest News
is climb bio inc. still worth holding after the dipPortfolio Value Report & Low Risk High Win Rate Stock Picks - Newser
What recovery options are there for Climb Bio Inc.Gold Moves & Risk Controlled Stock Alerts - Newser
Market reaction to Climb Bio Inc.’s recent newsMarket Performance Summary & Fast Entry High Yield Stock Tips - Newser
Is Climb Bio Inc. stock poised for growthJuly 2025 Chart Watch & Reliable Momentum Entry Alerts - Newser
Multi factor analysis applied to Climb Bio Inc.Quarterly Earnings Report & AI Based Buy/Sell Signal Reports - Newser
Sentiment analysis tools applied to Climb Bio Inc.2025 Volatility Report & Weekly Hot Stock Watchlists - Newser
Is Climb Bio Inc. a strong growth stockJuly 2025 Volume & Verified Chart Pattern Trade Signals - 더경남뉴스
Will Climb Bio Inc. stock recover after recent dropPortfolio Profit Report & Long Hold Capital Preservation Tips - Newser
How institutional ownership impacts Climb Bio Inc. stockJuly 2025 Trends & Long-Term Capital Growth Strategies - Newser
Climb Bio shares fall 1.29% after-hours following announcement of CLYM116 webcast event. - AInvest
Does Climb Bio Inc. have pricing powerJuly 2025 Rallies & Expert Approved Trade Ideas - خودرو بانک
What is Climb Bio Inc. s P E ratio telling usJuly 2025 Update & Weekly Breakout Stock Alerts - خودرو بانک
Climb Bio shares rise 2.05% premarket after announcing CLYM116 webcast event. - AInvest
Exit strategy if you’re trapped in Climb Bio Inc.July 2025 Catalysts & Safe Investment Capital Preservation Plans - Newser
Climb Bio to Host Webcast Highlighting CLYM116 and the IgA Nephropathy (IgAN) Opportunity on September 29, 2025 - Yahoo Finance
Can Climb Bio Inc. sustain earnings growthWeekly Market Report & Entry Point Strategy Guides - خودرو بانک
Automated trading signals detected on Climb Bio Inc.2025 Technical Overview & Expert Verified Stock Movement Alerts - Newser
Is Climb Bio Inc. showing signs of accumulationJuly 2025 Outlook & Real-Time Stock Price Movement Reports - Newser
Climb Bio, Inc. (CLYM)'s Technical Outlook is Bright After Key Golden Cross - sharewise.com
Statistical indicators supporting Climb Bio Inc.’s strengthPortfolio Performance Report & Long Hold Capital Preservation Plans - Newser
What MACD and RSI say about Climb Bio Inc.Analyst Downgrade & Weekly Setup with ROI Potential - Newser
Does Climb Bio Inc. have a sustainable dividend2025 Market WrapUp & Long Hold Capital Preservation Tips - khodrobank.com
What’s the outlook for Climb Bio Inc.’s sectorMarket Performance Summary & Low Risk Profit Maximizing Plans - خودرو بانک
Is Climb Bio Inc. reversing from oversold territory2025 Short Interest & Growth Oriented Trading Recommendations - Newser
Is Climb Bio Inc. still worth holding after the dipWeekly Risk Report & AI Based Buy and Sell Signals - Newser
Is Climb Bio Inc. stock forming a triangle patternJuly 2025 Big Picture & Real-Time Buy Signal Notifications - خودرو بانک
Order flow analysis tools used on Climb Bio Inc.Weekly Stock Summary & Proven Capital Preservation Methods - Newser
Will Climb Bio Inc. benefit from geopolitical trendsWeekly Profit Recap & Fast Moving Trade Plans - خودرو بانک
Applying chart zones and confluence areas to Climb Bio Inc.Portfolio Risk Report & Smart Swing Trading Alerts - Newser
Does Climb Bio Inc. outperform in volatile marketsTrade Analysis Summary & Free Accurate Trade Setup Notifications - خودرو بانک
What’s the analyst consensus on Climb Bio Inc.July 2025 Price Swings & Daily Price Action Insights - خودرو بانک
Is Climb Bio Inc. forming bullish engulfing patternsJuly 2025 Opening Moves & Daily Profit Focused Stock Screening - خودرو بانک
Applying Wyckoff theory to Climb Bio Inc. stock2025 Winners & Losers & Verified Technical Signals - Newser
What MACD and RSI say about Climb Bio IncTrade Analysis Summary & Verified Entry Point Detection - Newser
Climb Bio Inc. Uptrend in Early Stages Indicators Say YesPortfolio Update Summary & High Return Stock Watch Alerts - beatles.ru
Evaluating Climb Bio Inc. with trendline analysis2025 Market Overview & Weekly High Return Opportunities - Newser
Climb Bio Inc. stock daily chart insights2025 Winners & Losers & Long-Term Growth Stock Strategies - Newser
Pattern recognition hints at Climb Bio Inc. upsidePortfolio Gains Summary & High Accuracy Trade Signal Alerts - Newser
Is Climb Bio Inc. forming a reversal patternWall Street Watch & Long-Term Investment Growth Plans - Newser
Climb Bio Inc Stock (CLYM) Financials Data
Revenue
Net Income
Cash Flow
EPS
Climb Bio Inc Stock (CLYM) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Pimblett Emily | SVP, Finance & CAO |
Jun 20 '25 |
Sale |
1.24 |
1,242 |
1,540 |
18,888 |
| Pimblett Emily | SVP, Finance & CAO |
Mar 20 '25 |
Sale |
1.31 |
1,199 |
1,571 |
15,130 |
| Pimblett Emily | CHIEF ACCOUNTING OFFICER |
Dec 19 '24 |
Sale |
2.02 |
1,235 |
2,495 |
11,329 |
| Pimblett Emily | CHIEF ACCOUNTING OFFICER |
Sep 20 '24 |
Sale |
8.18 |
1,191 |
9,741 |
7,564 |
1.40%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):